Relating to the regulation of medical cannabidiol, by altering the list of debilitating medical conditions and changing the definition of medical cannabidiol under the medical cannabidiol Act

The bill requires that any certification made by a health care practitioner for a patient for any medical condition not explicitly included on the list of debilitating medical conditions shall be made by a health care practitioner pursuant to reasonable medical evidence, in good faith, in the best interest of the patient, without fraudulent intent, and with the same reasonable medical judgment and prudence exercised according to generally accepted medical practice. Under current law, a health care practitioner may only issue a written certification for a debilitating medical condition explicitly included on the list of debilitating medical conditions. A written certification may be renewed on an annual basis if the health care practitioner determines that the patient continues to suffer from the debilitating medical condition. The bill alters the definition of medical cannabidiol by increasing the allowable tetrahydrocannabinol (THC) level in medical cannabidiol from no more than 3 percent to no more than 13 percent. The medical cannabidiol board retains the authority to recommend increasing the allowable THC level.